Russian attackers were behind the hack of the European Medicines Agency EMA in 2020. They had “unauthorized access to knowledge of COVID-19 vaccines and personal correspondence” for at least four ...

Q1 2025 Management View CEO Christopher Missling highlighted key updates on the Alzheimer's treatment, blarcamesine. He emphasized the potential of the drug to offer "a scalable treatment alternative ...

The reassessment of Leqembi’s safety data follows the agency’s previous recommendation of the drug for use in the EU.

The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...